Malignant melanoma and the sentinel lymph node biopsy.
Kuhn
J A
JA
Baylor University Medical Center, Department of Surgery, Dallas, Texas, USA.
McCarty
T M
TM
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy / Q000379:methods; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004396:Coloring Agents; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000601:surgery; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008297:Male; D008545:Melanoma / Q000737:chemistry / Q000000981:diagnostic imaging / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D008751:Methylene Blue; D008875:Middle Aged; D014442:Monophenol Monooxygenase / Q000235:genetics; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D009367:Neoplasm Staging / Q000379:methods*; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012334:RNA, Neoplasm / Q000032:analysis / Q000235:genetics; D011877:Radionuclide Imaging; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D013194:Staining and Labeling; D016019:Survival Analysis; D013671:Technetium Tc 99m Sulfur Colloid
D014408:Biomarkers, Tumor; D004396:Coloring Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011994:Recombinant Proteins; D013671:Technetium Tc 99m Sulfur Colloid; D014442:Monophenol Monooxygenase; D008751:Methylene Blue